Overview Efficacy and Safety of HCP1102 Capsule Status: Completed Trial end date: 2015-07-01 Target enrollment: Participant gender: Summary Efficacy and safety of HCP1102 capsule : A randomized, double-blind, active-controlled, multicenter phase 3 clinical trial. Phase: Phase 3 Details Lead Sponsor: Hanmi Pharmaceutical Company Limited